Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Expo on Google News
SYS-CON.TV
Cloud Expo & Virtualization 2009 East
PLATINUM SPONSORS:
IBM
Smarter Business Solutions Through Dynamic Infrastructure
IBM
Smarter Insights: How the CIO Becomes a Hero Again
Microsoft
Windows Azure
GOLD SPONSORS:
Appsense
Why VDI?
CA
Maximizing the Business Value of Virtualization in Enterprise and Cloud Computing Environments
ExactTarget
Messaging in the Cloud - Email, SMS and Voice
Freedom OSS
Stairway to the Cloud
Sun
Sun's Incubation Platform: Helping Startups Serve the Enterprise
POWER PANELS:
Cloud Computing & Enterprise IT: Cost & Operational Benefits
How and Why is a Flexible IT Infrastructure the Key To the Future?
Click For 2008 West
Event Webcasts
Boehringer Ingelheim Announces Equine Research Awards
Occidental, Auburn each receive $25,000 for equine pigeon fever research

ST. JOSEPH, Mo., Dec. 3, 2012 /PRNewswire/ -- Researchers at two universities will be studying equine pigeon fever (Corynebacterium pseudotuberculosis) as recipients of the 2012 Advancement of Equine Research Awards, sponsored by Boehringer Ingelheim Vetmedica, Inc. (BIVI).

(Logo:  http://photos.prnewswire.com/prnh/20120925/CG80722LOGO)

Proposals by Roberta R. Pollock, Ph.D., professor of biology at Occidental College, and Allison J. Stewart, BVSc, professor of equine internal medicine at Auburn University, were selected by a panel of equine practitioners and university professors and researchers in veterinary medicine. Each award will provide $25,000 for 12-month research programs at each institution. The research awards were announced during the recent 2012 American Association of Equine Practitioners Annual Convention in Anaheim, Calif.

"The quality of equine research proposals this year was exceptional," says Steve Grubbs, DVM, PhD, DACVIM equine professional services, BIVI. "Although this is an academic award, the top priority is to identify projects that ultimately can improve the quality of life for horses and their owners."

Dr. Pollock will focus her efforts on combining equine disease infection studies with a mouse model for pigeon fever to identify and clone protective protein antigens from Corynebacterium pseudotuberculosis. Areas of research will include the pathophysiology of Corynebacterium pseudotuberculosis and development of an equine challenge model, and comparison of host immunity between infections resulting in internal infection and recurrent infection in recovered horses.

Dr. Stewart, assisted by graduate student Marta Barbra Recreo, will look into the transmission of Corynebacterium pseudotuberculosis in horses by houseflies. Like Dr. Pollock, she will focus on pathophysiology and a challenge model, as well as seasonality of Corynebacterium pseudotuberculosis infection and studies of insect vectors.

The topic for the 2013 awards will be announced next spring. Veterinarians, diagnosticians, and public and private researchers in the United States and Canada are eligible to submit proposals. Awards will be selected based on established criteria, including potential impact on the equine industry; originality and scientific quality; and probability of success in completing the yearlong studies.

"I am encouraged by the quality of the proposals submitted this year," Dr. Grubbs says. "BIVI is proud to take a leading role in helping provide equine health solutions, but we would not be nearly as successful without the ongoing research conducted by dedicated research and veterinary medical professionals around the country."

For more information and complete submission instructions, please visit www.equinediseaseresearch.com.

About Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 44,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.

As a central element of its culture, Boehringer Ingelheim pledges to act socially responsible. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim's endeavours.

In 2011, Boehringer Ingelheim achieved net sales of about $17.1 billion (13.2 billion euro). R&D expenditure in the business area Prescription Medicines corresponds to 23.5% of its net sales.

For more information, please visit http://us.boehringer-ingelheim.com and follow us on Twitter at http://twitter.com/boehringerus.

SOURCE Boehringer Ingelheim

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Cloud Developer Stories
Marketers in global manufacturing businesses are looking to improve customer engagement and increase marketing effectiveness as they support prospects and customers through the discovery and buying process. To be successful, these marketers need to quickly transition from convent...
The upcoming HIT-PH Conference in Metro Manila on May 22-23 focuses on the rapid advance of Information Technology in this sector. “The Philippine healthcare industry is entering the digital age,” according to the conference organizers, Exist Healthcare IT and Goldcrest Communic...
Web conferencing in a public cloud has the same risks as any other cloud service. If you have ever had concerns over the types of data being shared in your employees’ web conferences, such as IP, financials or customer data, then it’s time to look at web conferencing in a private...
SYS-CON Events announced today that ActiveState, providers of Stackato, the platform for the agile enterprise, has been named “Silver Sponsor” of SYS-CON's 2nd DevOps Summit, which will take place on June 10–12, 2014, at the Javits Center in New York City, New York. ActiveState ...
Dell and Red Hat Inc. have announced the availability of co-engineered, enterprise-grade, private cloud solutions based on OpenStack, the Dell Red Hat Cloud Solution, powered by Red Hat Enterprise Linux OpenStack Platform. The companies also have extended their collaboration to ...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021



SYS-CON Featured Whitepapers
ADS BY GOOGLE

Breaking Cloud Computing News

DUBLIN, Ireland, April 17, 2014 /PRNewswire/ --